Sign in to see private stats on your profile page — or add photo, interests, videos, mentoring, etc.

    June Lee, MD

    SchoolUCSF School of Medicine
    Address550 16th. Street
    San Francisco CA 94158
    vCardDownload vCard
      Other Positions
      TitleDirector, CTSI T1 Translational Research

      Collapse Biography 
      Collapse Education and Training
      University of California, DavisM.D.School of Medicine1992
      Johns Hopkins UniversityB.S.Chemistry1988

      Collapse Overview 
      Collapse Overview
      June Lee, MD, is the Director of the Catalyst program at Clinical and Translational Science Institute (CTSI) and a Professor in the School of Medicine at UCSF. A key focus of her work at UCSF is to identify the most compelling discovery research and enabling and supporting the projects towards product and commercialization. She is the chief architect of the highly successful Catalyst Program which serves as an internal UCSF accelerator for therapeutics, devices, diagnostics, and digital health technologies. She also oversees key strategic partnerships at UCSF to include industry collaborations. Currently, she also serves as Chair of the Drug, Device, Discovery and Development (D4) workgroup of UC BRAID (University of California Biomedical Research Acceleration Integration and Development) and was previously the Vice-Chair of CTSA Translational Key Function Committee.

      Prior to UCSF, she worked at Genentech where as the therapeutic area head, she led early clinical development programs in Infectious Diseases, Cardiovascular/Metabolic Diseases, and Respiratory Diseases. In that role, she was responsible for the clinical strategy and execution of programs in the early clinical development stages and successfully developed pre-clinical and late stage research projects in a variety of therapeutic areas through IND clearance and early stage clinical proof of concept studies.

      Collapse ORNG Applications 
      Collapse Websites
      Collapse In The News
      Collapse Awarded Grants
      Collapse Twitter

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Scheerens H, Arron JR, Zheng Y, Putnam WS, Erickson RW, Choy DF, Harris JM, Lee J, Jarjour NN, Matthews JG. The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge. Clin Exp Allergy. 2014 Jan; 44(1):38-46. PMID: 24131304; PMCID: PMC4204278.
      2. Emu B, Luca D, Offutt C, Grogan JL, Rojkovich B, Williams MB, Tang MT, Xiao J, Lee JH, Davis JC. Safety, pharmacokinetics, and biologic activity of pateclizumab, a novel monoclonal antibody targeting lymphotoxin a: results of a phase I randomized, placebo-controlled trial. Arthritis Res Ther. 2012; 14(1):R6. PMID: 22225620; PMCID: PMC3392792.
      3. Haselkorn T, Lee JH, Mink DR, Weiss ST. Racial disparities in asthma-related health outcomes in severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol. 2008 Sep; 101(3):256-63. PMID: 18814448.
        View in: PubMed
      4. Campbell JD, Borish L, Haselkorn T, Rasouliyan L, Lee JH, Wenzel SE, Sullivan SD. The response to combination therapy treatment regimens in severe/difficult-to-treat asthma. Eur Respir J. 2008 Nov; 32(5):1237-42. PMID: 18684845.
        View in: PubMed
      5. Chen H, Johnson CA, Haselkorn T, Lee JH, Israel E. Subspecialty differences in asthma characteristics and management. Mayo Clin Proc. 2008 Jul; 83(7):786-93. PMID: 18613995; PMCID: PMC3102298.
      6. Peters AT, Klemens JC, Haselkorn T, Weiss ST, Grammer LC, Lee JH, Chen H. Insurance status and asthma-related health care utilization in patients with severe asthma. Ann Allergy Asthma Immunol. 2008 Apr; 100(4):301-7. PMID: 18450113.
        View in: PubMed
      7. Chen H, Blanc PD, Hayden ML, Bleecker ER, Chawla A, Lee JH. Assessing productivity loss and activity impairment in severe or difficult-to-treat asthma. Value Health. 2008 Mar-Apr; 11(2):231-9. PMID: 18380635.
        View in: PubMed
      8. Lee JH, Haselkorn T, Borish L, Rasouliyan L, Chipps BE, Wenzel SE. Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study. Chest. 2007 Dec; 132(6):1882-9. PMID: 18079222.
        View in: PubMed
      9. Chen H, Gould MK, Blanc PD, Miller DP, Kamath TV, Lee JH, Sullivan SD. Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease. J Allergy Clin Immunol. 2007 Aug; 120(2):396-402. PMID: 17561244.
        View in: PubMed
      10. Chipps BE, Szefler SJ, Simons FE, Haselkorn T, Mink DR, Deniz Y, Lee JH. Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma. J Allergy Clin Immunol. 2007 May; 119(5):1156-63. PMID: 17397912.
        View in: PubMed
      11. Miller MK, Lee JH, Miller DP, Wenzel SE. Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med. 2007 Mar; 101(3):481-9. PMID: 16914299.
        View in: PubMed
      12. Miller MK, Lee JH, Blanc PD, Pasta DJ, Gujrathi S, Barron H, Wenzel SE, Weiss ST. TENOR risk score predicts healthcare in adults with severe or difficult-to-treat asthma. Eur Respir J. 2006 Dec; 28(6):1145-55. PMID: 16870656.
        View in: PubMed
      13. Lee JH, Haselkorn T, Chipps BE, Miller DP, Wenzel SE. Gender differences in IgE-mediated allergic asthma in the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study. J Asthma. 2006 Apr; 43(3):179-84. PMID: 16754518.
        View in: PubMed
      14. Slavin RG, Haselkorn T, Lee JH, Zheng B, Deniz Y, Wenzel SE. Asthma in older adults: observations from the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) study. Ann Allergy Asthma Immunol. 2006 Mar; 96(3):406-14. PMID: 16597074.
        View in: PubMed
      15. Lee JH, Kaminski N, Dolganov G, Grunig G, Koth L, Solomon C, Erle DJ, Sheppard D. Interleukin-13 induces dramatically different transcriptional programs in three human airway cell types. Am J Respir Cell Mol Biol. 2001 Oct; 25(4):474-85. PMID: 11694453.
        View in: PubMed
      16. Huang XZ, Wu JF, Ferrando R, Lee JH, Wang YL, Farese RV, Sheppard D. Fatal bilateral chylothorax in mice lacking the integrin alpha9beta1. Mol Cell Biol. 2000 Jul; 20(14):5208-15. PMID: 10866676; PMCID: PMC85969.
      June's Networks
      Related Concepts
      Derived automatically from this person's publications.
      People in Profiles who have published with this person.
      Related Authors
      People who share related concepts with this person.
      Back to TOP